The motivational component of withdrawal in opiate addiction: Role of associative learning and aversive memory in opiate addiction from a behavioral, anatomical and functional perspective

Reviews in the Neurosciences

Volumn 16, Issue 3, 2005, Pages 255-276

  Frenois, François ^a,b   Le Moine, Catherine ^a   Cador, Martine ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b INSTITUT FRANÇOIS MAGENDIE   (France)

Author keywords

Behavior; c fos imaging; Conditioned place aversion; Dopamine; Extended amygdala; In situ hybridization; Incentive learning; Memory; Rat brain

Indexed keywords

DOPAMINE; NALOXONE;

AMYGDALOID NUCLEUS; ASSOCIATIVE MEMORY; AVERSION; BEHAVIOR; CONDITIONING; DOPAMINERGIC SYSTEM; DRUG WITHDRAWAL; EMOTION; ENVIRONMENT; HUMAN; MEMORY; MOTIVATION; OPIATE ADDICTION; PRIORITY JOURNAL; RELAPSE; REVIEW; STATE DEPENDENT LEARNING; WITHDRAWAL SYNDROME;

EID: 27844469793     PISSN: 03341763     EISSN: None     Source Type: Journal    
DOI: 10.1515/REVNEURO.2005.16.3.255     Document Type: Review

References (154)

1. Acquas E, Di Chiara G. Depression of mesolimbic dopamine transmission and sensitization to morphine during opiate abstinence. J Neurochem 1992; 58: 1620-1625.
2. Ahmed SH, Walker JR, Koob GF. Persistent increase in the motivation to take heroin in rats with a history of drug escalation. Neuropsychopharmacology 2000; 22: 413-421.
3. Alheid GF. Extended amygdala and basal forebrain. Ann NY Acad Sci 2003; 985: 185-205.
4. Alheid GF, Heimer L. New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid, and corticopetal components of substantia innominata. Neuroscience 1988; 27: 1-39.
5. Anagnostaras SG, Robinson TE. Sensitization to the psychomotor stimulant effects of amphetamine: modulation by associative learning. Behav Neurosci 1996; 110: 1397-1414.
6. Aston-Jones G, Delfs JM, Druhan J, Zhu Y. The bed nucleus of the stria terminalis. A target site for noradrenergic actions in opiate withdrawal. Ann NY Acad Sci 1999; 877: 486-498.
7. Baldwin HA, Koob GF. Rapid induction of conditioned opiate withdrawal in the rat. Neuropsychopharmacology 1993; 8: 15-21.
8. Bardo MT. Neuropharmacological mechanisms of drug reward: beyond dopamine in the nucleus accumbens. Grit Rev Neurobiol 1998; 12: 37-67.
9. Bechara A, Harrington F, Nader K, van der Kooy D. Neurobiology of motivation: double dissociation of two motivational mechanisms mediating opiate reward in drug-naive versus drug-dependent animals. Behav Neurosci 1992; 106: 798-807.
10. Bechara A, Nader K, van der Kooy D. Neurobiology of withdrawal motivation: evidence for two separate aversive effects produced in morphine-naive versus morphine-dependent rats by both naloxone and spontaneous withdrawal. Behav Neurosci 1995; 109: 91-105.
11. Bechara A, Nader K, van der Kooy D. A two-separate-motivational-systems hypothesis of opioid addiction. Pharmacol Biochem Behav 1998; 59: 1-17.
12. Beckmann AM, Matsumoto I, Wilce PA. Immediate early gene expression during morphine withdrawal. Neuropharmacology 1995; 34: 1183-1189.
13. Berke JD, Hyman SE. Addiction, dopamine, and the molecular mechanisms of memory. Neuron 2000; 25: 515-532.
14. Berridge KC, Robinson TE. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Rev 1998; 28: 309-369.
15. Bindra D. How adaptative behavior is produced: a perceptual-motivation alternative to response reinforcement. Behav Brain Sci 1978; 1: 41-91.
16. Bissiere S, Humeau Y, Luthi A. Dopamine gates LTP induction in lateral amygdala by suppressing feedforward inhibition. Nat Neurosci 2003; 6: 587-592.
17. Bonci A, Williams JT. Increased probability of GABA release during withdrawal from morphine. J Neurosci 1997; 17: 796-803.
18. Brinley-Reed M, McDonald AJ. Evidence that dopaminergic axons provide a dense innervation of specific neuronal subpopulations in the rat basolateral amygdala. Brain Res 1999; 850: 127-135.
19. Brown EE, Robertson GS, Fibiger HC. Evidence for conditional neuronal activation following exposure to a cocaine-paired environment: role of forebrain limbic structures. J Neurosci 1992; 12: 4112-4121.
20. Caillé S, Espejo EF, Koob GF, Stinus L. Dorsal and median Raphe serotonergic system lesion does not alter the opiate withdrawal syndrome. Pharmacol Biochem Behav 2002; 72: 979-986.
21. Caillé S, Espejo EF, Reneric JP, Cador M, Koob GF, Stinus L. Total neurochemical lesion of noradrenergic neurons of the locus coeruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal. J Pharmacol Exp Ther 1999; 290: 881-892.
22. Caillé S, Stinus L, Espejo EF, De Deurwaerdere P, Spampinato U, Koob GF. Inhibition of 5-HT neurotransmission increases clonidine protective effects on naloxone-induced conditioned place aversion in morphine-dependent rats. Neuropsychopharmacology 2003; 28: 276-283.
23. Cardinal RN, Parkinson JA, Hall J, Everitt BJ. Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex. Neurosci Biobehav Rev 2002; 26: 321-352.
24. Carr KD, Kutchukhidze N, Park TH. Differential effects of mu and kappa opioid antagonists on Fos-like immunoreactivity in extended amygdala. Brain Res 1999; 822: 34-42.
25. Cassell MD, Freedman LJ, Shi C. The intrinsic organization of the central extended amygdala. Ann NY Acad Sci 1999; 877: 217-241.
26. Chahl LA, Leah J, Herdegen T, Trueman L, Lynch-Frame AM. Distribution of c-Fos in guinea-pig brain following morphine withdrawal. Brain Res 1996; 717: 127-134.
27. Chieng B, Keay KA, Christie MJ. Increased fos-like immunoreactivity in the periaqueductal gray of anaesthetised rats during opiate withdrawal. Neurosci Lett 1995; 183: 79-82.
28. Childress AR, Hole AV, Ehrman RN, Robbins SJ, McLellan AT, O'Brien CP. Cue reactivity and cue reactivity interventions in drug dependence. NIDA Res Monogr 1993; 137: 73-95.
29. Coco ML, Kuhn CM, Ely TD, Kilts CD. Selective activation of mesoamygdaloid dopamine neurons by conditioned stress: attenuation by diazepam. Brain Res 1992; 590: 39-47.
30. Cornish JL, Duffy P, Kalivas PW. A role for nucleus accumbens glutamate transmission in the relapse to cocaine-seeking behavior. Neuroscience 1999; 93: 1359-1367.
31. Cornish JL, Kalivas PW. Glutamate transmission in the nucleus accumbens mediates relapse in cocaine addiction. J Neurosci 2000; 20: RC89.
32. Cornish JL, Kalivas PW. Cocaine sensitization and craving: differing roles for dopamine and glutamate in the nucleus accumbens. J Addict Dis 2001; 20: 43-54.
33. Crippens D, Robinson TE. Withdrawal from morphine or amphetamine: different effects on dopamine in the ventral-medial striatum studied with microdialysis. Brain Res 1994; 650: 56-62.
34. Davis M, Rainnie D, Cassell M. Neurotransmission in the rat amygdala related to fear and anxiety. Trends Neurosci 1994; 17: 208-214.
35. Dayas CV, Buller KM, Crane JW, Xu Y, Day TA. Stressor categorization: acute physical and psychological stressors elicit distinctive recruitment patterns in the amygdala and in medullary noradrenergic cell groups. Eur J Neurosci 2001; 14: 1143-1152.
36. De Vries TJ, Schoffelmeer AN, Binnekade R, Mulder AH, Vanderschuren LJ. Drug-induced reinstatement of heroin- and cocaine-seeking behaviour following long-term extinction is associated with expression of behavioural sensitization. Eur J Neurosci 1998; 10: 3565-3571.
37. De Vries TJ, Schoffelmeer AN, Binnekade R, Vanderschuren LJ. Dopaminergic mechanisms mediating the incentive to seek cocaine and heroin following long-term withdrawal of IV drug self-administration. Psychopharmacology (Berl) 1999; 143: 254-260.
38. Delfs JM, Zhu Y, Druhan JP, Aston-Jones G. Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature 2000; 403: 430-434.
39. Delfs JM, Zhu Y, Druhan JP, Aston-Jones GS. Origin of noradrenergic afferents to the shell subregion of the nucleus accumbens: anterograde and retrograde tract-tracing studies in the rat. Brain Res 1998; 806: 127-140.
40. Deroche V, Le Moal M, Piazza PV. Cocaine self-administration increases the incentive motivational properties of the drug in rats. Eur J Neurosci 1999; 11: 2731-2736.
41. Di Chiara G. Drug addiction as dopamine-dependent associative learning disorder. Eur J Pharmacol 1999; 375: 13-30.
42. Di Chiara G, North RA. Neurobiology of opiate abuse. Trends Pharmacol Sci 1992; 13: 185-193.
43. Diana M, Muntoni AL, Pistis M, Melis M, Gessa GL. Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal. Eur J Neurosci 1999; 11: 1037-1041.
44. Diana M, Pistis M, Muntoni A, Gessa G. Profound decrease of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats. J Pharmacol Exp Ther 1995; 272: 781-785.
45. 2-like receptor stimulation during opiate withdrawal. J Pharmacol Exp Ther 2000; 294: 531-538.
46. Dworkin SI, Guerin GF, Co C, Goeders NE, Smith JE. Lack of an effect of 6-hydroxydopamine lesions of the nucleus accumbens on intravenous morphine self-administration. Pharmacol Biochem Behav 1988; 30: 1051-1057.
47. Espejo EF, Cador M, Stinus L. Ethopharmacological analysis of naloxone-precipitated morphine withdrawal syndrome in rats: a newly-developed "etho-score". Psychopharmacology (Berl) 1995; 122: 122-130.
48. Ettenberg A, Pettit HO, Bloom FE, Koob GF. Heroin and cocaine intravenous self-administration in rats: mediation by separate neural systems. Psychopharmacology (Berl) 1982; 78: 204-209.
49. Everitt BJ. Craving cocaine cues: cognitive neuroscience meets drug addiction research. Trends Cogn Sci 1997; 1: 1-2.
50. Everitt BJ, Cardinal RN, Parkinson JA, Robbins TW. Appetitive behavior: impact of amygdala-dependent mechanisms of emotional learning. Ann NY Acad Sci 2003; 985: 233-250.
51. Everitt BJ, Parkinson JA, Olmstead MC, Arroyo M, Robledo P, Robbins TW. Associative processes in addiction and reward. The role of amygdala-ventral striatal subsystems. Ann NY Acad Sci 1999; 877: 412-438.
52. Everitt BJ, Wolf ME. Psychomotor stimulant addiction: a neural systems perspective. J Neurosci 2002; 22: 3312-3320.
53. Franken IH. Drug craving and addiction: integrating psychological and neuropsychopharmacological approaches. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 563-579.
54. Franklin TR, Druhan JP. Expression of Fos-related antigens in the nucleus accumbens and associated regions following exposure to a cocaine-paired environment. Eur J Neurosci 2000; 12: 2097-2106.
55. Freedman LJ, Cassell MD. Distribution of dopaminergic fibers in the central division of the extended amygdala of the rat. Brain Res 1994; 633: 243-252.
56. Frenois F, Cador M, Caillé S, Stinus L, Le Moine C. Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal. Eur J Neurosci 2002; 16: 1377-1389.
57. Frenois F, Stinus L, Di Blasi F, Cador M, Le Moine C. A specific limbic circuit underlies opiate withdrawal memories. J Neurosci 2005; 25: 1366-1374.
58. Gellert VF, Holtzman SG. Development and maintenance of morphine tolerance and dependence in the rat by scheduled access to morphine drinking solutions. J Pharmacol Exp Ther 1978; 205: 536-546.
59. Georges F, Aston-Jones G. Prolonged activation of mesolimbic dopaminergic neurons by morphine withdrawal following clonidine: participation of imidazoline and norepinephrine receptors. Neuropsychopharmacology 2003; 28: 1140-1149.
60. Georges F, Stinus L, Le Moine C. Mapping of c-fos gene expression in the brain during morphine dependence and precipitated withdrawal, and phenotypic identification of the striatal neurons involved. Eur J Neurosci 2000; 12: 4475-4486.
61. Gerrits MA, Ramsey NF, Wolterink G, van Ree JM. Lack of evidence for an involvement of nucleus accumbens dopamine DI receptors in the initiation of heroin self-administration in the rat. Psychopharmacology (Berl) 1994; 114: 486-494.
62. Gerrits MA, Van Ree JM. Effect of nucleus accumbens dopamine depletion on motivational aspects involved in initiation of cocaine and heroin self-administration in rats. Brain Res 1996; 713: 114-124.
63. Grace AA, Rosenkranz JA. Regulation of conditioned responses of basolateral amygdala neurons. Physiol Behav 2002; 77: 489-493.
64. Gracy KN, Dankiewicz LA, Koob GF. Opiate withdrawal-induced fos immunoreactivity in the rat extended amygdala parallels the development of conditioned place aversion. Neuropsychopharmacology 2001; 24: 152-160.
65. Grimm JW, See RE. Dissociation of primary and secondary reward-relevant limbic nuclei in an animal model of relapse. Neuropsychopharmacology 2000; 22: 473-479.
66. 2 dopamine receptor antagonist on Pavlovian fear conditioning. Behav Neurosci 2000; 114: 647-651.
67. 1 dopamine receptor involvement in Pavlovian fear conditioning. Brain Res 1999; 827: 28-40.
68. Hall J, Thomas KL, Everitt BJ. Fear memory retrieval induces CREB phosphorylation and Fos expression within the amygdala. Eur J Neurosci 2001; 13: 1453-1458.
69. Hamlin A, Buller KM, Day TA, Osborne PB. Peripheral withdrawal recruits distinct central nuclei in morphine-dependent rats. Neuropharmacology 2001; 41: 574-581.
70. Hand TH, Koob GF, Stinus L, Le Moal M. Aversive properties of opiate receptor blockade: evidence for exclusively central mediation in naive and morphine-dependent rats. Brain Res 1988; 474: 364-368.
71. Harlan RE, Garcia MM. Drugs of abuse and immediate-early genes in the forebrain. Mol Neurobiol 1998; 16: 221-267.
72. 2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome. Nature 1994; 371: 155-157.
73. Harris GC, Aston-Jones G. Enhanced morphine preference following prolonged abstinence: association with increased fos expression in the extended amygdala. Neuropsychopharmacology 2003; 28: 292-299.
74. Heinrichs S, Menzaghi F, Schulteis G, Koob GF, Stinus L. Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal. Behav Pharmacol 1995; 6: 74-80.
75. Hotsenpiller G, Giorgetti M, Wolf ME. Alterations in behaviour and glutamate transmission following presentation of stimuli previously associated with cocaine exposure. Eur J Neurosci 2001; 14: 1843-1855.
76. Hutcheson DM, Everitt BJ, Robbins TW, Dickinson A. The role of withdrawal in heroin addiction: enhances reward or promotes avoidance? Nat Neurosci 2001; 4: 943-947.
77. Jaffe JH. Drug Addiction and Drug Abuse. New York: Pergamon Press, 1990.
78. Kalivas PW, Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Rev 1991; 16: 223-244.
79. Kelley AE, Domesick VB, Nauta WJ. The amygdalostriatal projection in the rat: an anatomical study by anterograde and retrograde tracing methods. Neuroscience 1982; 7: 615-630.
80. Koob GF. Drug addiction: the yin and yang of hedonic homeostasis. Neuron 1996; 16: 893-896.
81. Koob GF, Bloom FE. Cellular and molecular mechanisms of drug dependence. Science 1988; 242: 715-723.
82. Koob GF, Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science 1997; 278: 52-58.
83. Koob GF, Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 2001; 24: 97-129.
84. Koob GF, Maldonado R, Stinus L. Neural substrates of opiate withdrawal. Trends Neurosci 1992; 15: 186-191.
85. Koob GF, Stinus L, Le Moal M, Bloom FE. Opponent process theory of motivation: neurobiological evidence from studies of opiate dependence. Neurosci Biobehav Rev 1989; 13: 135-140.
86. Laviolette SR, Nader K, van der Kooy D. Motivational state determines the functional role of the mesolimbic dopamine system in the mediation of opiate reward processes. Behav Brain Res 2002; 129: 17-29.
87. Le Guen S, Gestreau C, Besson JM. Sensitivity to naloxone of the behavioral signs of morphine withdrawal and c-Fos expression in the rat CNS: a quantitative dose-response analysis. J Comp Neurol 2001; 433: 272-296.
88. Maldonado R, Stinus L, Gold LH, Koob GF. Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J Pharmacol Exp Ther 1992; 261: 669-677.
89. Maren S. Long-term potentiation in the amygdala: a mechanism for emotional learning and memory. Trends Neurosci 1999; 22: 561-567.
90. Maren S. The amygdala, synaptic plasticity, and fear memory. Ann NY Acad Sci 2003; 985: 106-113.
91. McDonald AJ. Organization of amygdaloid projections to the prefrontal cortex and associated striatum in the rat. Neuroscience 1991; 44: 1-14.
92. McDonald AJ. Topographical organization of amygdaloid projections to the caudatoputamen, nucleus accumbens, and related striatal-like areas of the rat brain. Neuroscience 1991; 44: 15-33.
93. McDonald AJ, Shammah-Lagnado SJ, Shi C, Davis M. Cortical afferents to the extended amygdala. Ann NY Acad Sci 1999; 877: 309-338.
94. Meil WM, See RE. Lesions of the basolateral amygdala abolish the ability of drug associated cues to reinstate responding during withdrawal from self-administered cocaine. Behav Brain Res 1997; 87: 139-148.
95. Mucha RF. Is the motivational effect of opiate withdrawal reflected by common somatic indices of precipitated withdrawal? A place conditioning study in the rat. Brain Res 1987; 418: 214-220.
96. Nader K, Bechara A, van der Kooy D. Neurobiological constraints on behavioral models of motivation. Annu Rev Psychol 1997; 48: 85-114.
97. Nader K, Le Doux JE. Inhibition of the mesoamygdala dopaminergic pathway impairs the retrieval of conditioned fear associations. Behav Neurosci 1999; 113: 891-901.
98. Nader K, van der Kooy D. Deprivation state switches the neurobiological substrates mediating opiate reward in the ventral tegmental area. J Neurosci 1997; 17: 383-390.
99. Neisewander JL, Baker DA, Fuchs RA, Tran-Nguyen LT, Palmer A, Marshall JF. Fos protein expression and cocaine-seeking behavior in rats after exposure to a cocaine self-administration environment. J Neurosci 2000; 20: 798-805.
100. O'Brien CP, Childress AR, McLellan AT, Ehrman RN. A learned model of addiction. In: O'Brien CP, Jaffe JH, eds. Addictive States. New York: Raven Press, 1992; 157-178.
101. Pare D, Royer S, Smith Y, Lang EJ. Contextual inhibitory gating of impulse traffic in the intra-amygdaloid network. Ann NY Acad Sci 2003; 985: 78-91.
102. Pert A, Post R, Weiss SR. Conditioning as a critical determinant of sensitization induced by psychomotor stimulants. NIDA Res Monogr 1990; 97: 208-241.
103. Pettit HO, Ettenberg A, Bloom FE, Koob GF, Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats. Psychopharmacology (Berl) 1984; 84: 167-173.
104. Pezzone MA, Lee WS, Huffman GE, Rabin BS. Induction of c-Fos irnmunoreactivity in the rat forebrain by conditioned and unconditioned aversive stimuli. Brain Res 1992; 597: 41-50.
105. Phelix CF, Liposits Z, Paull WK. Monoamine innervation of bed nucleus of stria terminalis: an electron microscopic investigation. Brain Res Bull 1992; 28: 949-965.
106. Pitkanen A, Pikkarainen M, Nurminen N, Ylinen A. Reciprocal connections between the amygdala and the hippocampal formation, perirhinal cortex, and post-rhinal cortex in rat. A review. Ann NY Acad Sci 2000; 911: 369-391.
107. Pitkanen A, Savander M, Nurminen N, Ylinen A. Intrinsic synaptic circuitry of the amygdala. Ann NY Acad Sci 2003; 985: 34-49.
108. Pitkanen A, Savander V, Le Doux JE. Organization of intra-amygdaloid circuitries in the rat: an emerging framework for understanding functions of the amygdala. Trends Neurosci 1997; 20: 517-523.
109. Robinson TE, Berridge KC. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 1993; 18: 247-291.
110. Robinson TE, Berridge KC. The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction 2000; 95 (Suppl 2): S91-117.
111. Robinson TE, Kolb B. Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J Neurosci 1997; 17: 8491-8497.
112. Robinson TE, Kolb B. Morphine alters the structure of neurons in the nucleus accumbens and neocortex of rats. Synapse 1999; 33: 160-162.
113. Rodriguez de Fonseca F, Navarro M. Role of the limbic system in dependence on drugs. Ann Med 1998; 30: 397-405.
114. Rosenkranz JA, Grace AA. Modulation of basolateral amygdala neuronal firing and afferent drive by dopamine receptor activation in vivo. J Neurosci 1999; 19: 11027-11039.
115. Rosenkranz JA, Grace AA. Dopamine attenuates prefrontal cortical suppression of sensory inputs to the basolateral amygdala of rats. J Neurosci 2001; 21: 4090-4103.
116. Rosenkranz JA, Grace AA. Cellular mechanisms of infralimbic and prelimbic prefrontal cortical inhibition and dopaminergic modulation of basolateral amygdala neurons in vivo. J Neurosci 2002; 22: 324-337.
117. Rosenkranz JA, Grace AA. Dopamine-mediated modulation of odour-evoked amygdala potentials during Pavlovian conditioning. Nature 2002; 417: 282-287.
118. Rosenkranz JA, Grace AA. Affective conditioning in the basolateral amygdala of anesthetized rats is modulated by dopamine and prefrontal cortical inputs. Ann NY Acad Sci 2003; 985: 488-491.
119. Rossetti ZL, Hmaidan Y, Gessa GL. Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. Eur J Pharmacol 1992; 221: 227-234.
120. Royer S, Martina M, Pare D. An inhibitory interface gates impulse traffic between the input and output stations of the amygdala. J Neurosci 1999; 19: 10575-10583.
121. Sandner G, Oberling P, Silveira MC, Di Scala G, Rocha B, Bagri A, Depoortere R. What brain structures are active during emotions? Effects of brain stimulation elicited aversion on c-fos immunoreactivity and behavior. Behav Brain Res 1993; 58: 9-18.
122. Schafe GE, Nadel NV, Sullivan GM, Harris A, Le Doux JE. Memory consolidation for contextual and auditory fear conditioning is dependent on protein synthesis, PKA, and MAP kinase. Learn Mem 1999; 6: 97-110.
123. Schafe GE, Nader K, Blair HT, Le Doux JE. Memory consolidation of Pavlovian fear conditioning: a cellular and molecular perspective. Trends Neurosci 2001; 24: 540-546.
124. Schenk S, Partridge B. Sensitization and tolerance in psychostimulant self-administration. Pharmacol Biochem Behav 1997; 57: 543-550.
125. Schmued LC. Diagonal ventral forebrain continuum has overlapping telencephalic inputs and brainstem outputs which may represent loci for limbic/autonomic integration. Brain Res 1994; 667: 175-191.
126. Schroeder BE, Holahan MR, Landry CF, Kelley AE. Morphine-associated environmental cues elicit conditioned gene expression. Synapse 2000; 37: 146-158.
127. Schulteis G, Ahmed SH, Morse AC, Koob GF, Everitt BJ. Conditioning and opiate withdrawal. Nature 2000; 405: 1013-1014.
128. Schulteis G, Markou A, Gold LH, Stinus L, Koob GF. Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis. J Pharmacol Exp Ther 1994; 271: 1391-1398.
129. See RE. Neural substrates of conditioned-cued relapse to drug-seeking behavior. Pharmacol Biochem Behav 2002; 71: 517-529.
130. Self DW, Nestler EJ. Relapse to drug-seeking: neural and molecular mechanisms. Drug Alcohol Depend 1998; 51: 49-60.
131. Shaham Y, Rajabi H, Stewart J. Relapse to heroin-seeking in rats under opioid maintenance: the effects of stress, heroin priming, and withdrawal. J Neurosci 1996; 16: 1957-1963.
132. Shalev U, Grimm JW, Shaham Y. Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev 2002; 54: 1-42.
133. Shaw-Lutchman TZ, Barrot M, Wallace T, Gilden L, Zachariou V, Impey S, Duman RS, Storm D, Nestler EJ. Regional and cellular mapping of cAMP response element-mediated transcription during naltrexone-precipitated morphine withdrawal. J Neurosci 2002; 22: 3663-3672.
134. Shippenberg TS, Elmer GI. The neurobiology of opiate reinforcement. Crit Rev Neurobiol 1998; 12: 267-303.
135. Siegel S. Drug anticipation and drug addiction. The 1998 H. David Archibald Lecture. Addiction 1999; 94: 1113-1124.
136. Stewart J. Pathways to relapse: the neurobiology of drug- and stress-induced relapse to drug-taking. J Psychiatry Neurosci 2000; 25: 125-136.
137. Stewart J, Badiani A. Tolerance and sensitization to the behavioral effects of drugs. Behav Pharmacol 1993; 4: 289-312.
138. Stewart J, de Wit H, Eikelboom R. Role of unconditioned and conditioned drug effects in the self-administration of opiates and stimulants. Psychol Rev 1984; 91: 251-268.
139. Stewart J, Eikelboom R. Conditioned drug effects. In: Iversen L, ed. Handbook of Psychopharmacology. New York: Plenum, 1986; 1-57.
140. Stinus L, Caillé S, Koob GF. Opiate withdrawal-induced place aversion lasts for up to 16 weeks. Psychopharmacology 2000; 149: 115-120.
141. Stinus L, Le Moal M, Koob GF. Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience 1990; 37: 767-773.
142. Stornetta RL, Norton FE, Guyenet PG. Autonomic areas of rat brain exhibit increased Fos-like immunoreactivity during opiate withdrawal in rats. Brain Res 1993; 624: 19-20.
143. Tirelli E, Terry P. Ampl/etamine-induced conditioned activity and sensitization: the role of habituation to the test context and the involvement of Pavlovian processes. Behav Pharmacol 1998; 9: 409-419.
144. Van Ree JM, Gerrits MA, Vanderschuren LJ. Opioids, reward and addiction: an encounter of biology, psychology, and medicine. Pharmacol Rev 1999; 51: 341-396.
145. 2 dopamine receptor agonist. Neuropsychopharmacology 2000; 23: 307-315.
146. Weiss F, Ciccocioppo R, Parsons LH, Katner S, Liu X, Zorrilla EP, Valdez GR, Ben-Shahar O, Angeletti S, Richter RR. Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors. Ann NY Acad Sci 2001; 937: 1-26.
147. White FJ, Kalivas PW. Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend 1998; 51: 141-153.
148. Whitelaw RB, Markou A, Robbins TW, Everitt BJ. Excitotoxic lesions of the basolateral amygdala impair the acquisition of cocaine-seeking behaviour under a second-order schedule of reinforcement. Psychopharmacology (Berl) 1996; 127: 213-224.
149. Wikler A. Conditioning factors in opiate addiction and relapse. In: Willner DI, Kassenbaum GG, eds. Narcotics. New York: McGraw-Hill, 1965; 7-21.
150. Wikler A. Dynamics of drug dependence. Implications of a conditioning theory for research and treatment. Arch Gen Psychiatry 1973; 28: 611-616.
151. Wise RA. Catecholamine theories of reward: a critical review. Brain Res 1978; 152: 215-247.
152. Wise RA. Neurobiology of addiction. Curr Opin Neurobiol 1996; 6: 243-251.
153. Wolf ME. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog Neurobiol 1998; 54: 679-720.
154. Wright CI, Beijer AV, Groenewegen HJ. Basal amygdaloid complex afferents to the rat nucleus accumbens are compartmentally organized. J Neurosci 1996; 16: 1877-1893.